Skip to main content
Livermore
Livermore
ZHEN

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Ocular Therapeutix, Inc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of OCUL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders1973187−7
Shares137.4M58.9K157.1M+19.8M (+14.4%)
Value$1.01B$469.9K$1.45B+$447.2M (+44.4%)

3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Ocular Therapeutix, Inc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to OCUL in Q2 2025
InstitutionSharesValue% of portfolio
IMC-Chicago, LLC207,765$1.93M0.05%
Weiss Asset Management LP187,615$1.74M0.03%
Dark Forest Capital Management LP161,903$1.50M0.06%
Millennium Management LLC119,146$1.11M0.00%
Hudson Bay Capital Management LP54,090$502.0K0.00%
Y-Intercept (Hong Kong) Ltd36,815$341.6K0.01%
Brevan Howard Capital Management LP32,328$300.0K0.00%
Leonteq Securities AG25,000$232.0K0.01%
Cambridge Investment Research Advisors, Inc.24,100$224.0K0.00%
Two Sigma Securities, LLC23,231$215.6K0.03%
Jain Global LLC19,646$182.3K0.00%
Commonwealth Equity Services, LLC14,360$133.0K0.00%
Marex Group plc12,358$114.7K0.00%
Quantessence Capital LLC11,467$106.4K0.03%
Axq Capital, LP10,720$99.5K0.03%
Mackenzie Financial Corp10,157$94.3K0.00%
Clear Street Markets LLC8,531$79.2K0.03%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.991$9.00K0.00%
Ameritas Advisory Services, LLC291$2.70K0.00%
Global Retirement Partners, LLC225$2.09K0.00%
Parkside Financial Bank & Trust129$1.20K0.00%
Essential Partners LLC33$3060.00%
Larson Financial Group LLC8$740.00%
Twin Peaks Wealth Advisors, LLC2$250.00%

Sold out (31)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of OCUL in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Perceptive Advisors LLC915,775$6.71M
Silverarc Capital Management, LLC551,570$4.04M
First Trust Advisors LP217,970$1.60M
Cubist Systematic Strategies, LLC137,871$1.01M
StemPoint Capital LP124,523$912.8K
ExodusPoint Capital Management, LP96,185$705.0K
Canada Pension Plan Investment Board81,800$599.6K
Tudor Investment Corp Et Al79,648$583.8K
Corebridge Financial, Inc.77,460$567.8K
Two Sigma Advisers, LP73,100$535.8K
Polar Asset Management Partners Inc.56,670$415.4K
Graham Capital Management, L.P.48,749$357.3K
Warren Averett Asset Management, LLC47,691$349.6K
Voloridge Investment Management, LLC45,437$333.1K
Squarepoint Ops LLC45,054$330.2K
Caxton Associates LLP33,821$247.9K
Nottingham Advisors, Inc.33,083$242.5K
Algert Global LLC29,020$212.7K
XTX Topco Ltd22,605$165.7K
HSBC Holdings PLC19,573$140.9K
Bayesian Capital Management, LP17,000$124.6K
Aigen Investment Management, LP16,164$118.5K
Gsa Capital Partners LLP15,306$112.0K
Principal Financial Group Inc12,623$92.5K
Quantinno Capital Management LP11,079$81.2K
Skopos Labs, Inc.5,238$38.4K
Signaturefd, LLC781$5.72K
Quent Capital, LLC750$5.50K
Russell Investments Group, Ltd.120$880
Coldstream Capital Management Inc70$514
Stephens Consulting, LLC50$367

Not filed for Q2 2025 yet (3)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Grant/GrossMendelsohn, LLC47,691$387.7K
Credit Agricole S A11,100$81.4K
Lindbrook Capital, LLC117$858